CR Bard Inc

Most Recent

  • uploads///revenue estimates
    Earnings Report

    Baxter Exhibits Strong 1Q16 Performance, Beat Estimates

    On April 26, 2016, Baxter International (BAX) released its 1Q16 earnings. After the announcement, Baxter’s share price rose ~1% from $43.63 on April 25, 2016, due to the company’s better-than-expected 1Q16 results.

    By Sarah Collins
  • uploads///geographic strength
    Company & Industry Overviews

    How BD-Bard Acquisition Will Strengthen International Presence

    C.R. Bard (BCR) has grown significantly outside the United States in recent years, driven by its international channel expansion strategy.

    By Sarah Collins
  • uploads///covidien synergies
    Company & Industry Overviews

    How Medtronic Is Delivering on Its Covidien Synergies

    In January 2015, Medtronic (MDT) acquired Covidien for ~$43 billion in cash and MDT stock in a tax inversion deal.

    By Sarah Collins
  • uploads///tr
    Consumer

    A Brief Look at Dividend Aristocrats

    The S&P 500 Dividend Aristocrat Index is made up of 51 S&P 500 (SPY) (SPX-INDEX) companies that have increased their dividends for 25 successive years.

    By Amanda Lawrence
  • uploads///PERFORMANCE
    Earnings Report

    Key Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings

    On April 26, 2016, Varian Medical Systems (VAR) released its 2Q17 earnings. VAR beat consensus estimates for revenues in 2Q17 by ~0.8% and reported in-line earnings per share.

    By Sarah Collins
  • uploads///capital allocation
    Earnings Report

    How BDX Returns Value to Its Shareholders

    BD announced a quarterly cash dividend of $0.73 per share on July 25, 2017.

    By Sarah Collins
  • uploads///capital allocaton
    Company & Industry Overviews

    Baxter’s Latest Dividend and Share Repurchase Authorization

    Baxter International (BAX) announced a quarterly cash dividend of $0.13 per share on November 8, 2016.

    By Sarah Collins
  • uploads///performance
    Company & Industry Overviews

    Baxter International’s Recent Product Launches and Partnerships

    Baxter International’s R&D investments were around $150 million in 2Q16, which represents a YoY (year-over-year) increase of around 1%.

    By Sarah Collins
  • uploads///Portfolio Breakdown of the VMRGX
    Fund Managers

    Vanguard Morgan Growth Fund’s Sector Composition in YTD 2016

    Information technology is by far the biggest invested sector in the Vanguard Morgan Growth Fund (VMRGX), forming over a third of the total portfolio.

    By David Ashworth
  • uploads///PERFORMANCE
    Company & Industry Overviews

    Varian Medical Systems Attempts to Improve Its Performance Growth

    Varian Medical Systems (VAR) raised its guidance for fiscal 2016 in the view of higher-than-expected 3Q16 results reported on July 27.

    By Sarah Collins
  • uploads///capital allocation
    Company & Industry Overviews

    What’s BSX’s Capital Allocation Strategy Going Forward?

    In August 2015, BSX acquired American Medical Systems’ male urology business for $1.6 billion in cash and milestone-based payments of $50 million.

    By Sarah Collins
  • uploads///market share
    Company & Industry Overviews

    How Is Varian Positioned in the Particle Therapy Business?

    Varian Medical Systems (VAR) had gross orders value of $310 million in 2015.

    By Sarah Collins
  • uploads///growth strategy
    Company & Industry Overviews

    Growth Strategies Driving Varian Medical Systems’ Revenue

    Varian Medical Systems has ventured into the proton therapy business and has a huge product pipeline in this area. The company generated approximately $300 million through its proton therapy business in 2015.

    By Sarah Collins
  • uploads///radiotherapy gaps
    Company & Industry Overviews

    Varian Medical Systems’ Growth Potential in Radiation Oncology

    Varian Medical Systems’ next big technology innovation will be high-definition radiotherapy, which is an intelligent treatment delivery system that aims to achieve 100% radiation exposure for the tumor.

    By Sarah Collins
  • uploads///business segments
    Company & Industry Overviews

    Where Does Varian Medical Systems Get Most of Its Revenue?

    Varian Medical Systems’ Imaging Components segment accounts for approximately 19% of the company’s total revenue. The segment reported a revenue decline of ~10% in 2015.

    By Sarah Collins
  • uploads///oncology
    Company & Industry Overviews

    A Look at C. R. Bard’s Oncology Business Segment

    C. R. Bard’s (BCR) Oncology segment contributes around 27% of the total revenues of the company.

    By Sarah Collins
  • uploads///revenue growth
    Company & Industry Overviews

    Company Overview: An Introduction to C. R. Bard

    Headquartered in Murray Hill, New Jersey, C. R. Bard (BCR) is a leading medical technology company in the United States.

    By Sarah Collins
  • Company & Industry Overviews

    Why VMRGX’s Year-to-Date 2016 Has Been Lackluster

    As of May 27, 2016, the Vanguard Morgan Growth Fund Investor Shares (VMRGX) had fallen by 0.7% YTD (year-to-date) in 2016.

    By David Ashworth
  • uploads///profitability
    Earnings Report

    Baxter’s 1Q16 Profitability and 2016 Guidance

    Baxter International (BAX) revised its 2016 guidance as the company reported a strong 1Q16. Sales guidance for the year is updated from the 2%–3% range to approximately 3%.

    By Sarah Collins
  • uploads///hospital products
    Earnings Report

    Innovation Drove Baxter’s Hospital Products Sales in 1Q16

    Baxter International (BAX) reported ~$2.4 billion in total revenues in 1Q16. Of that, ~$1.5 billion was contributed by the company’s Hospital Products business.

    By Sarah Collins
  • uploads///strategic initiatives
    Company & Industry Overviews

    Strategic Initiatives Driving Baxter’s Margin Expansion Goal

    Baxter witnessed a series of changes in 2015, including a change in management, operational structure, and the establishment of a new strategic framework.

    By Sarah Collins
  • uploads///history of U
    Company & Industry Overviews

    Key Regulations that Affect Medical Device Companies

    The US Food and Drug Administration’s Center for Devices for Radiological Health (or USFDA/CDRH) regulates the medical device industry in the United States.

    By Sarah Collins
  • uploads///Graph Part
    Company & Industry Overviews

    How are XLV’s Moving Averages Trending?

    Out of 56 stocks in XLV’s portfolio, a total of 32 stocks were trading above their 20-day moving average.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    The Biotech Sector Is in a Downward Long-Term Trend

    Though most of the biotech stocks rebounded from the recent lows, the long-term trend for biotech seems to be heading downward.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.